Lamotrigine is a new antiepileptic drug that may possess unique cognit
ive and behavioral characteristics. Although lamotrigine can produce n
eurobehavioral toxicity, it is generally well tolerated. In one study
directly comparing lamotrigine to placebo as add-on therapy in patient
s with intractable epilepsy, no objective cognitive effects were obser
ved in a limited neuropsychological battery. Several studies have demo
nstrated favorable effects of lamotrigine on psychological well-being
that were not explained by simple effects on seizure frequency and sev
erity. In direct comparisons with carbamazepine and phenytoin, lamotri
gine has been reported to produce positive effects on quality of life
scales of patient perception. In addition, positive behavioral effects
have also been observed in two blinded studies and several open trial
s for patients with severe mental disability and refractory epilepsy.
Future studies with more extensive neuropsychological assessments are
needed to delineate the differential cognitive and behavioral effects
of lamotrigine in epilepsy and psychiatric disorders.